Filament administers psilocybin to 14 participants in Health Canada sanctioned clinical trial

Mugglehead
By Rowan DunneSep 1, 2022, 10:07 pm178 pts
A group of up-and-coming psychedelic therapists have now legally experienced the mind-bending effects of psilocybin mushrooms. On Thursday, Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) announced that it had recently dosed 14 healthy subjects with its natural psilocybin drug candidate. The…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Silk Road Drug Market Operator Pardoned By Trump Calls For More Prisoners To Be Freed, As Democrats Criticize His Clemency 53

New Jersey Officials Celebrate Completion Of Marijuana Training Academy Curriculum To Help People Enter The Legal Industry 51

Canadian Cannabis Sales Bounced Again 32

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.